Your browser doesn't support javascript.
loading
Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas.
Wang, Yan-Xia; Wu, Haibo; Ren, Yong; Lv, Shengqing; Ji, Chengdong; Xiang, Dongfang; Zhang, Mengsi; Lu, Huimin; Fu, Wenjuan; Liu, Qing; Yan, Zexuan; Ma, Qinghua; Miao, Jingya; Cai, Ruili; Lan, Xi; Wu, Bin; Wang, Wenying; Liu, Yinhua; Wang, Dai-Zhong; Cao, Mianfu; He, Zhicheng; Shi, Yu; Ping, Yifang; Yao, Xiaohong; Zhang, Xia; Zhang, Peng; Wang, Ji Ming; Wang, Yan; Cui, Youhong; Bian, Xiu-Wu.
Affiliation
  • Wang YX; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Wu H; Department of Pathology, The First Affiliated Hospital of University of Science and Technology of China, 230036, Hefei, Anhui, China.
  • Ren Y; Intelligent Pathology Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, 230036, Hefei, Anhui, China.
  • Lv S; Department of Pathology, General Hospital of Central Theater Command of PLA, 627 Wuluo Road, Hongshan District, 430070, Wuhan, Hubei, China.
  • Ji C; Xinqiao Hospital, Army Medical University, 400038, Chongqing, China.
  • Xiang D; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Zhang M; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Lu H; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Fu W; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Liu Q; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Yan Z; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Ma Q; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Miao J; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Cai R; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Lan X; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Wu B; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Wang W; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Liu Y; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Wang DZ; Department of Pathology, The First Affiliated Hospital of Wannan Medical College, 241001, Wuhu, Anhui, China.
  • Cao M; Department of Pathology, Taihe Hospital, Hubei University of Medicine, 442000, Shiyan, Hubei, China.
  • He Z; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Shi Y; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Ping Y; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Yao X; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Zhang X; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Zhang P; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Wang JM; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China.
  • Wang Y; Laboratory of Cancer and Immunometabolism, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, 21703, US.
  • Cui Y; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China. wang_yan1977@hotmail.com.
  • Bian XW; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (former Third Military Medical University), 400038, Chongqing, China. cuiyouhongx@yahoo.com.
Signal Transduct Target Ther ; 7(1): 72, 2022 03 11.
Article de En | MEDLINE | ID: mdl-35273141

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du cervelet / Médulloblastome Limites: Animals / Child / Humans Langue: En Journal: Signal Transduct Target Ther Année: 2022 Type de document: Article Pays d'affiliation: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du cervelet / Médulloblastome Limites: Animals / Child / Humans Langue: En Journal: Signal Transduct Target Ther Année: 2022 Type de document: Article Pays d'affiliation: Chine